When treating MUTZ-3 cells with 1 μM talazoparib or 10 μM olaparib, the reduction of cell viability of AML cells went along with a higher percentage of apoptotic cells as shown by Annexin-V/7-AAD staining in flow cytometric analysis (Fig. 4c). Here, ANXA5 is linked to acute myeloid leukemia.